From R&D tax credits to the high risk of innovation to decades long product life cycles, the life science industry is like no other.The life sciences industry is comprised of Pharmaceutical, Biotech, Medical Device and Diagnostic companies. Within each of these market segments is further fragmentation. For example within the Biotech industry segment, the various business models often seen include: R&D companies, product based commercial companies, virtual development, R&D grant funded, collaborator funded, and of course public and private.